首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes.
【24h】

Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes.

机译:澳大利亚腹膜透析患者的多菌性腹膜炎:预测因素,治疗和结果。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The study aim was to examine the frequency, predictors, treatment, and clinical outcomes of peritoneal dialysis-associated polymicrobial peritonitis. STUDY DESIGN: Observational cohort study using ANZDATA (The Australia and New Zealand Dialysis and Transplant Registry) data. SETTING & PARTICIPANTS: All Australian peritoneal dialysis patients between October 2003 and December 2006. PREDICTORS: Age, sex, race, body mass index, baseline renal function, late referral, kidney disease, smoking status, comorbidity, peritoneal permeability, center, state, organisms, and antibiotic regimen. OUTCOMES & MEASUREMENTS: Polymicrobial peritonitis occurrence, relapse, hospitalization, catheter removal, hemodialysis transfer, and death. RESULTS: 359 episodes of polymicrobial peritonitis occurred in 324 individuals, representing 10% of all peritonitis episodes during 6,002 patient-years. The organisms isolated included mixed Gram-positive and Gram-negative organisms (41%), pure Gram-negative organisms (22%), pure Gram-positive organisms (25%), and mixed bacteria and fungi (13%). There were no significant independent predictors of polymicrobial peritonitis except for the presence of chronic lung disease. Compared with single-organism infections, polymicrobial peritonitis was associated with higher rates of hospitalization (83% vs 68%; P < 0.001), catheter removal (43% vs 19%; P < 0.001), permanent hemodialysis transfer (38% vs 15%; P < 0.001), and death (4% vs 2%; P = 0.03). Isolation of fungus or Gram-negative bacteria was the primary predictor of adverse clinical outcomes. Pure Gram-positive peritonitis had the best clinical outcomes. Patients who had their catheters removed >1 week after polymicrobial peritonitis onset were significantly more likely to be permanently transferred to hemodialysis therapy than those who had earlier catheter removal (92% vs 81%; P = 0.05). LIMITATIONS: Limited covariate adjustment. Residual confounding and coding bias could not be excluded. CONCLUSIONS: Polymicrobial peritonitis can be treated successfully using antibiotics alone without catheter removal in most cases, particularly when only Gram-positive organisms are isolated. Isolation of Gram-negative bacteria (with or without Gram-positive bacteria) or fungi carries a worse prognosis and generally should be treated with early catheter removal and appropriate antimicrobial therapy.
机译:背景:本研究的目的是检查腹膜透析相关的多菌性腹膜炎的发生频率,预测因素,治疗方法和临床结果。研究设计:使用ANZDATA(澳大利亚和新西兰透析与移植注册机构)数据进行的观察性队列研究。地点和参与者:2003年10月至2006年12月之间的所有澳大利亚腹膜透析患者。预测者:年龄,性别,种族,体重指数,基线肾功能,晚期转诊,肾脏疾病,吸烟状况,合并症,腹膜通透性,中枢,状态,生物和抗生素治疗方案。结果与测量:微生物腹膜炎的发生,复发,住院,拔除导管,血液透析转移和死亡。结果:324个人中发生了359次多微生物腹膜炎发作,占6002患者年中所有腹膜炎发作的10%。分离出的生物包括革兰氏阳性和革兰氏阴性混合生物(41%),纯革兰氏阴性生物(22%),纯革兰氏阳性生物(25%)以及细菌和真菌混合菌(13%)。除存在慢性肺部疾病外,没有任何关于微生物腹膜炎的重要独立预测因子。与单一生物体感染相比,多菌性腹膜炎的住院率更高(83%vs 68%; P <0.001),导管移除(43%vs 19%; P <0.001),永久性血液透析转移(38%vs 15) %; P <0.001)和死亡(4%vs 2%; P = 0.03)。分离真菌或革兰氏阴性细菌是不良临床结果的主要预测指标。纯革兰氏阳性腹膜炎的临床效果最好。在发生多发性微生物腹膜炎后> 1周内拔除导管的患者比那些早先拔除导管的患者更有可能永久转入血液透析治疗(92%比81%; P = 0.05)。局限性:协变量调整有限。不能排除残留的混淆和编码偏差。结论:在大多数情况下,不用导管就可单独使用抗生素成功治疗多发性微生物性腹膜炎,尤其是仅分离革兰氏阳性菌时。革兰氏阴性菌(有或没有革兰氏阳性菌)或真菌的分离预后较差,通常应及早拔除导管并进行适当的抗菌治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号